Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1992-10

AUTHORS

Mohamed-Salah I. Abaza, M. Zouhair Atassi

ABSTRACT

Amino acid substitutions outside protein antigenic sites are very frequently assumed to exert no effect on binding to antiprotein antibodies, especially if these are monoclonal antibodies (mAbs). In fact, a very popular method for localization of residues in protein antigenic sites is based on the interpretation that whenever a replacement causes a change in binding to antibody, then that residue will be located in the antigenic site. To test this assumption, mAbs of predetermined specificity were prepared by immunization with a free (i.e., without coupling to any carrier) synthetic peptide representing region 94–100 of sperm whale myoglobin (Mb). The cross-reactivities and relative affinities of three mAbs with eight Mb variants were studied. Five Mb variants which had no substitutions within the boundaries of the designed antigenic site exhibited remarkable, and in two cases almost complete, loss in cross-reactivity relative to the reference antigen, sperm whale Mb. Two myoglobins, each of which had one substitution within region 94–100, showed little or no reactivity with the three mAbs. It is concluded that substitutions outside an antigenic site can exert drastic effects on the reactivity of a protein with mAbs against the site and that caution should be exercised in interpreting cross-reactivity data of proteins to implicate residues directly in an antigenic site. More... »

PAGES

433-444

Journal

TITLE

The Protein Journal

ISSUE

5

VOLUME

11

Related Patents

  • Methods For Increasing Thermogenic Adipocytes
  • Human Leukocyte Antigen (Hla)-Based Hiv Vaccine
  • Drug Screening, Genetic Engineering
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Fc Fusion Proteins For Enhancing The Immunogenicity Of Protein And Peptide Antigens
  • Preventing The Viral Entry Process Into Target Cells, By Inhibiting The Binding Of Viral Surface Glycoprotein To Cell Surface Cd4, To Fusion Coreceptors Ccr5 Chemokine Receptors And The Transient Conformation Fusion Intermediate That Ultimately Folds Into A Conformation Capable Of Mediating Fusion
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Recombinant Tumor Specific Antibody And Use Thereof
  • Method For Down-Regulating Gdf-8 Activity
  • Therapeutic And Diagnostic Domain 1 Β2gpi Polypeptides And Methods Of Using Same
  • For Drug Screening, Diagnosis Of Scurvy
  • Bind To The Cd23 Type Ii Molecule; For The Treatment Of Autoimmune And Inflammatory Disorders, Rheumatoid Arthritis
  • Peptide Composition As Immunogen For The Treatment Of Allergy
  • Enhancement Of Antibody-Cytokine Fusion Protein Mediated Immune Responses By Combined Treatment With Immunocytokine Uptake Enhancing Agents
  • Methods Of Modulating Cark Protein Activity
  • Methods For Producing Humanized Antibodies And Improving Yield Of Antibodies Or Antigen Binding Fragments In Cell Culture
  • Isolated Nucleotide Sequences Encoding Gdf Traps
  • Therapeutic Method For Reducing Angiogenesis
  • Antibodies And Related Molecules That Bind To Psca Proteins
  • Isolated Polynucleotide That Encodes An Actriia-Fc Fusion Polypeptide
  • Method Of Producing Vaccines From Protein Signal Oligopeptides
  • Heterodimeric Fusion Proteins Useful For Targeted Immune Therapy And General Immune Stimulation
  • Novel Peptides Based On Conserved Regions Of Regulatory And Auxiliary Hiv Proteins, Antigens In Free Or Carrier-Bound Form Comprising One Of The Peptides, Vaccine Compositions Containing One Of The Antigens, Immunoassay Kits And A Method Of Detecting Antibodies, Induced By Hiv Using Such Antigens
  • Enhancing The Circulating Half-Life Of Antibody-Based Fusion Proteins
  • Hiv-1 South African Subtype C Env Proteins
  • For Inhibiting Expression Of Adhesion Molecules In Vascular Endothelial Cells, Diagnosis Of Arteriosclerosis
  • Method For Promoting Bone Growth Using Activin-Actriia Antagonists
  • Antibody For Use In The Treatment Of Cancer, Inflammation And Immunological Responses
  • Using A Substance Capable Of Inhibiting The Binding Between Parathyroid Hormone-Related Peptide (Pthrp) And A Receptor; Humanized Anti-Parathyroid Hormone Related Protein 1-34 (Anti-Pthrp (1-34)) Antibody
  • Activin-Actriia Antagonists For Treating A Follicle-Stimulating Horomone-Secreting Pituitary Tumor
  • Human Immunodeficiency Virus Immunogenic Composition
  • Nucleic Acid Encoding An Anti-Epcam Protein; Binds Human Epithelial Cell Adhesion Molecule; Immunoglobulin Light Chain Region Modified To Reduce Immunogenicity; Diagnosis, Prognosis And Treatment Of Cancer
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Polypeptide For Use In The Treatment Of Tumors, Autoimmune, Inflammatory And Viral Diseases
  • Methods Of Targeting Multiple Cytokines
  • Methods For Increasing Thermogenic Adipocytes
  • Enhancement Of Antibody-Mediated Immune Responses
  • Antibodies Directed Against Lymphocyte Activation Gene 3 (Lag-3)
  • Lymphocyte Controlling Polypeptide; For Use In The Treatment Of Allergies, Hodgkins's Disease And Lung Defects
  • Methods For Assaying Inhibition Of Hiv-1 Envelope Glycoprotein-Mediated Membrane Fusion
  • Vaccine ; Human Leukemia, Lymphoma Virus
  • A Polypeptide Selected From The Group Consisting Of A Sod-4 Polypeptide (Superoxide Dimutase) Having A Preferred Deduced Amino Acid Sequence And Fragments, Analogs And Derivatives Encoded By A Specific Polynucleotide
  • Mic-Binding Antibodies And Methods Of Use Thereof
  • Administering Anti-C5a Antibodies To Treat Blood And Toxin Disorders
  • Fc Fusion Proteins For Enhancing The Immunogenicity Of Protein And Peptide Antigens
  • Compositions Comprising Multiple Immunodeficiency Virus Subunits For Inducing An Immune Response
  • Antibodies To Truncated Vegf-D And Uses Thereof
  • Inoculating Female Birds In Egg Laying Age With Targeted Colony-Forming Immunogen, Allowing Time Sufficient To Permit Production In Bird Of Antibody, Harvesting Eggs, Separating Antibody-Containing Contents From Shell And Drying Them, Mixing With Feeds Or Water
  • Relates To Immunogen For Inducing Antibodies That Neutralize A Wide Spectrum Of Hiv Primary Isolates And Method Of Inducing Anti-Hiv Antibodies Using Such Immunogen
  • Peptide For Use In The Treatment Of Allergic Disorders
  • Method Of Producing An Hiv-1 Immune Response
  • Nematode Atp Synthase Subunit E Polypeptide
  • For Prevention Of Virus Infections, By Inducing Immune Responses To The Transition State Complexes Formed Upon Binding Of A Virus Enevelope Proteins To Receptor Polypeptides
  • Encodes Cytokine Fusion Proteins With An Increased Therapeutic Index; Able To Bind To More Than One Type Of Cytokine Receptor Expressed On Cells; For Treating Tumors; Immunotherapy; Antitumor Agents
  • For Use In Pharmaceutical And Diagnostic Formulations
  • Preventing Fusion Of Virus And Preferential Cells; Incubate Cells With Genetically Engineered Viral Particles And Viricide, Detect Reduction In Emission Energy, Reduction In Emission Indicates Prevention Of Viral Fusion And Infection
  • Method Of Promoting Bone Growth By An Anti-Actriia Antibody
  • Can Be Used To Vaccinate A Mammal Against Specific Self Or Non-Self Antigens
  • Recombinant Tumor Specific Antibody And Use Thereof
  • Methods And Materials Relating To Novel Cd39-Like Polypeptides
  • Methods Of Identifying Actriib Variants
  • Method For Producing An Actriib-Fc Fusion Polypeptide
  • Dna Sequence And Preparation Of Grass Pollen Allergen Phl P 4 By Recombinant Methods
  • Triggering Receptor Involved In Natural Cytotoxicity Mediated By Human Natural Killer Cells And Antibodies That Identify The Same
  • Monoclonal Antibodies Which Specifically Bind Human Cd23, The Low Affinity Receptor For Ige (Fcerii/Cd23), And Contain Either A Human Gamma-1 Or Human Gamma-3 Constant Domain; Useful For Modulating Or Inhibiting Induced Ige Expression
  • Methods And Compositions For Treating Ige-Related Disease Using Nnt-1 Inhibitors
  • Serpentine Transmembrane Antigens Expressed In Human Cancers And Uses Thereof
  • Screening Nucleotide Diphosphatatse By Contacting Nucleotide Diphosphate Substrate In Presence And Absense Of Compound And Measuring Enzyme Activity; Inhibitor Is Identified By Decrease In Activity
  • Monoclonal Antibody With Affinity To Defective Transferrin For Diagnosing Alcoholism; Immunoassay
  • Enhancing The Circulating Half-Life Of Antibody-Based Fusion Proteins
  • Enhancing The Circulating Half-Life Of Antibody-Based Fusion Proteins
  • Heterodimeric Fusion Proteins Useful For Targeted Immune Therapy And General Immune Stimulation
  • Ectodomain Of The Hiv-1iiib Envelope Glycoprotein Gp41 Fused To A Fragment Of The Influenza Virus Ha2 Hemagglutinin Protein. Immunization In Vivo Via An Intraperitoneal Prime Followed By Intranasal Or Intragastric Boosts With Gp41ha
  • Erbb4 Antagonists
  • Inoculating Female Birds In Egg Laying Age With Targeted Colony-Forming Immunogen, Allowing Time Sufficient To Permit Production In Bird Of Antibody, Harvesting Eggs, Separating Antibody-Containing Contents
  • Cytokine Fusion Proteins With An Increased Therapeutic Index; Able To Bind To More Than One Type Of Cytokine Receptor Expressed On Cells
  • Treating A Subject Afflicted With Hiv-1 By Administering Anti-Viral Agent Selected From A Nonnucleoside Reverse Transcriptase Inhibitor, A Nucleoside Reverse Transcriptase Inhibitor, A Hiv-1 Protease Inhibitor, And A Hiv-1 Fusion Or Viral Entry Inhibitor
  • Isolated Gdf Trap Polypeptide
  • Expression Vector Coding Nucleotide Sequences Comprising Novel Cytokine Upregulated By Interleukin-9 For Use In Treatment And Prevention Of Cell Hodgkin's Disease
  • Phosphoserine And Phosphothreonine Binding Modules. The Ww-Domain Containing Polypeptides Of The Invention Can Be Used, For Example, To Regulate Cell Growth; To Treat Neurodegenerative Diseases; To Screen For Substances That
  • Peptides Capable Of Inducing A Hiv-1 Specific Immune Response Without Antagonizing The Cytotoxic T-Cell Activity; Based On Hiv Gag P17 And P24 Proteins
  • Antibodies And Peptide Antigens For Producing Antibodies Having A Selective Binding Specificity To Bioactive Intact Parathyroid Hormone (Pth) 1-84
  • Isolation And Characterization Of The Csa Operon (Etec-Cs4 Pili) And Methods Of Using Same
  • Antibody To Receptor On The Surface Of Activated T-Cells: Act-4
  • Immunogenic Polypeptides For Inducing Anti-Self Ige Responses
  • Therapeutic Vaccine Anti-Hiv, Anti-Aids And Against Tumors And Syndromes Associated With Hiv Infection
  • Hybridoma Cell Line; Vehicles For Combating Viral Infections And Tumors
  • Non-Anaphylactogenic Ige Fusion Proteins
  • Monoclonal Antibody Reacting Specifically Reacting With Fas Ligand And Production Process Thereof
  • Antibodies Which Specifically Bind T Cell Inducible Factors (Tifs)
  • Use Of Gdf Traps To Treat Anemia
  • Methods For Treating Anemia In A Subject In Need Thereof
  • Γ-1 Anti-Human Cd23 Monoclonal Antibodies And Use Thereof As Therapeutics
  • Method Of Producing An Hiv-1 Immune Response
  • Assay For The Detection Of Phosphorylated Pth
  • Used To Produce Immunotoxins (Its) And Cytokines With A Reduced Ability To Promote Vascular Leak Syndrome (Vls)
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Nucleotide Sequences Coding Enzymatic Polypeptide For Use In The Treatment In Defects In Apoptosis
  • Modified Hiv-1gag P17 Peptide And Immunogenic Composition
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Therapeutic Vaccine Anti-Hiv, Anti-Aids And Against Tumors And Syndromes Associated With Hiv Infection
  • Γ-1 Anti-Human Cd23 Monoclonal Antibodies And Use Thereof As Therapeutics
  • Compound For Treatment Of Allergy And Asthma
  • Endothelialization Of Vascular Surfaces
  • Immunoglobulin For Use In The Diagnosis, Treatment And Prevention Of Allergies
  • For Treating Alzheimer's/Parkinson's Disease/Rheumatoid Arthritis/Sepsis/Stroke/Inflammation/Ischemia/Cardiovascular/ Liver Disease/Multiple Sclerosis/Acquired Immune Deficiency Syndrome(Aids)/Male Pattern Baldness/Tumors/Cancer
  • Methods Of Increasing Sarcolemmal Utrophin
  • Phosphoserine And Phosphothreonine Binding Modules. The Ww-Domain Containing Polypeptides Of The Invention Can Be Used, For Example, To Regulate Cell Growth; To Treat Neurodegenerative Diseases; To Screen For Substances That
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • Nucleotide Sequences Coding Enzymatic Polypeptide For Use In The Treatment In Defects In Apoptosis
  • Method Of Producing An Hiv-1 Immune Response
  • Peptides Comprising Helper T And B Cell Epitope Portions; Vaccines; Preventing Or Reducing Circulatory System Athero-Genic Activity
  • Compound For Treatment Of Allergy And Asthma
  • Dna Sequence And Preparation Of Grass Pollen Allergen Phl P 4 By Recombinant Methods
  • Variants Derived From Actriib And Uses Therefor
  • Methods And Compositions For Reducing Serum Lipids
  • Adminstering A Combination Of A Nucleic Acid Vaccine And A Recombinant Poxvirus Vaccine To Potentiate A Cd8+ Response To Human Immunodeficiency Virus-1 Epitopes
  • Method Of Producing An Hiv-1 Immune Response
  • Immunogen Adherence Inhibitor And Method Of Making And Using Same
  • Actriia Binding Agents And Uses Thereof
  • Method For Down-Regulating Gdf-8 Activity Using Immunogenic Gdf-8 Analogues
  • Variants Derived From Actriib And Uses Therefor
  • Selectively Delivering Interleukin-12 (Il-12) To A Target Antigen In A Mammal
  • Anti-Ccr5 Antibody
  • Truncated Actriib-Fc Fusion Protein
  • Modified Hiv Env Polypeptides
  • Immunogenic Composition
  • Coadministering An Antibody Specific For One Or More Of The Antigenic Determinants Characteristic Of Said Vaccine
  • Gamma-1 And Gamma-3 Anti-Human Cd23 Monoclonal Antibodies And Use Thereof As Therapeutics
  • Anti-Idiotypic Antibodies Against Antibodies Which Inhibit The Binding Of Immunoglobulin E To Its High Affinity Receptors
  • Functions By Preventing Attachment Or Adherence Of Colony Forming Immunogens In Rumen And Intestinal Tracts Of Host Food Animals; Made By Inoculating Female Birds With Immunogen, Harvesting Eggs Which Contain Antibodies, Adding To Feed
  • Variants Derived From Actriib
  • Nucleotide Sequences Coding Polypeptides For Use In The Treatment And Prevention Of Viral And Bacterial Disease
  • Antigenic Peptide For Inducing The Formation Of Antibodies
  • For Production Of Vaccines
  • Polypeptides And Fragments Of Polypeptides Containing Histidine Triad Residues Or Coiled-Coil Regions, Some Of Which Polypeptides Or Fragments Lie Between 80 And 680 Residues In Length. Also Disclosed Are Processes For
  • Serine-Threonine Kinase Gene
  • Neuregulin; Detecting Epidermal Growth Factor (Egfh2) Polypeptides Or Mrna For Diagnostic And Prognostic Purposes; Treating A Egfh2 Protein-Modulated Disorder Such As Cancer, Peripheral Neuropathy, Amyolotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease
  • Methods For Increasing Adiponectin
  • Combined Use Of Gdf Traps And Erythropoietin Receptor Activators To Increase Red Blood Cell Levels
  • For Generating An Immune Response In A Subject
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf01025020

    DOI

    http://dx.doi.org/10.1007/bf01025020

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1016163643

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/1280436


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amino Acid Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibody Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Binding Sites, Antibody", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carnivora", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chickens", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dogs", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dolphins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Epitopes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunization", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myoglobin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Peptide Fragments", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Species Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Structure-Activity Relationship", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tachyglossidae", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Whales", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, Baylor College of Medicine, 77030, Houston, Texas", 
              "id": "http://www.grid.ac/institutes/grid.39382.33", 
              "name": [
                "Department of Biochemistry, Baylor College of Medicine, 77030, Houston, Texas"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Abaza", 
            "givenName": "Mohamed-Salah I.", 
            "id": "sg:person.010356667154.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010356667154.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biochemistry, Baylor College of Medicine, 77030, Houston, Texas", 
              "id": "http://www.grid.ac/institutes/grid.39382.33", 
              "name": [
                "Department of Biochemistry, Baylor College of Medicine, 77030, Houston, Texas"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Atassi", 
            "givenName": "M. Zouhair", 
            "id": "sg:person.01022247072.83", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022247072.83"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/978-1-4613-3778-2_21", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037034586", 
              "https://doi.org/10.1007/978-1-4613-3778-2_21"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4615-8858-0_2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030236168", 
              "https://doi.org/10.1007/978-1-4615-8858-0_2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/205883a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009095762", 
              "https://doi.org/10.1038/205883a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4613-4190-1_2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017862294", 
              "https://doi.org/10.1007/978-1-4613-4190-1_2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/202496a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006658233", 
              "https://doi.org/10.1038/202496a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4613-4193-2_4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1089828740", 
              "https://doi.org/10.1007/978-1-4613-4193-2_4"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1992-10", 
        "datePublishedReg": "1992-10-01", 
        "description": "Amino acid substitutions outside protein antigenic sites are very frequently assumed to exert no effect on binding to antiprotein antibodies, especially if these are monoclonal antibodies (mAbs). In fact, a very popular method for localization of residues in protein antigenic sites is based on the interpretation that whenever a replacement causes a change in binding to antibody, then that residue will be located in the antigenic site. To test this assumption, mAbs of predetermined specificity were prepared by immunization with a free (i.e., without coupling to any carrier) synthetic peptide representing region 94\u2013100 of sperm whale myoglobin (Mb). The cross-reactivities and relative affinities of three mAbs with eight Mb variants were studied. Five Mb variants which had no substitutions within the boundaries of the designed antigenic site exhibited remarkable, and in two cases almost complete, loss in cross-reactivity relative to the reference antigen, sperm whale Mb. Two myoglobins, each of which had one substitution within region 94\u2013100, showed little or no reactivity with the three mAbs. It is concluded that substitutions outside an antigenic site can exert drastic effects on the reactivity of a protein with mAbs against the site and that caution should be exercised in interpreting cross-reactivity data of proteins to implicate residues directly in an antigenic site.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf01025020", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1297375", 
            "issn": [
              "1572-3887", 
              "1573-4943"
            ], 
            "name": "The Protein Journal", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "11"
          }
        ], 
        "keywords": [
          "amino acid substitutions", 
          "protein antigenic sites", 
          "acid substitutions", 
          "antigenic sites", 
          "localization of residues", 
          "sperm whale myoglobin", 
          "Mb variants", 
          "sperm whale Mb", 
          "whale Mb", 
          "whale myoglobin", 
          "protein", 
          "monoclonal antibodies", 
          "residues", 
          "predetermined specificity", 
          "relative affinity", 
          "synthetic peptides", 
          "drastic effect", 
          "myoglobin", 
          "sites", 
          "substitution", 
          "variants", 
          "mAbs", 
          "specificity", 
          "antibodies", 
          "localization", 
          "MB", 
          "peptides", 
          "affinity", 
          "effect", 
          "loss", 
          "cross-reactivity data", 
          "changes", 
          "antigen", 
          "replacement", 
          "demonstration", 
          "free synthetic peptide", 
          "data", 
          "fact", 
          "caution", 
          "popular method", 
          "reactivity", 
          "immunization", 
          "reference antigen", 
          "interpretation", 
          "boundaries", 
          "peptide immunization", 
          "method", 
          "assumption", 
          "cases", 
          "antiprotein antibodies"
        ], 
        "name": "Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: Demonstration with region 94\u2013100 (antigenic site 3) of myoglobin", 
        "pagination": "433-444", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1016163643"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf01025020"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "1280436"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf01025020", 
          "https://app.dimensions.ai/details/publication/pub.1016163643"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:47", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_261.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf01025020"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf01025020'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf01025020'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf01025020'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf01025020'


     

    This table displays all metadata directly associated to this object as RDF triples.

    218 TRIPLES      21 PREDICATES      101 URIs      87 LITERALS      26 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf01025020 schema:about N0b17695191e048f8a24544a4f8d4b817
    2 N0e68937751a74b47bce4f048c2c1b720
    3 N269d892068bf4d28bbdc54541766ee88
    4 N407ee46165124ad5b9ed5167826f952b
    5 N4e416633fd8745148e677ba8c5dbf8b7
    6 N5dfa40c770284e8e94c64df17c15c2f6
    7 N7aac7c8f239c45e6a1f4c17ed2052e13
    8 N837b3d3af26f46bc92bf7f9dd7596658
    9 N83d5e9b638a145c0a7f5f3eb09a83ccb
    10 N8418cd79479e497fbe177a7ddabda242
    11 N8b834647a89143598126075f3a601477
    12 N989c9cb5eb584255bde6abe8ccc84a37
    13 Na8e4006c9ce4468796441ab58ec78742
    14 Nb497dda242ac4e328acd060caef801dd
    15 Nc81b48ce974642a9bf4af2c10dae4abd
    16 Nc93074d899374ad4b1d4294ee5eb5827
    17 Ne45a5d486adf4b848e0655701eabd4ce
    18 Ne6b69568d67549aba37100f4f3ece91c
    19 Nf1cab84bd6184771ac94dea321085b30
    20 anzsrc-for:06
    21 anzsrc-for:0601
    22 schema:author Nbf173c99c66c4407857493f204701959
    23 schema:citation sg:pub.10.1007/978-1-4613-3778-2_21
    24 sg:pub.10.1007/978-1-4613-4190-1_2
    25 sg:pub.10.1007/978-1-4613-4193-2_4
    26 sg:pub.10.1007/978-1-4615-8858-0_2
    27 sg:pub.10.1038/202496a0
    28 sg:pub.10.1038/205883a0
    29 schema:datePublished 1992-10
    30 schema:datePublishedReg 1992-10-01
    31 schema:description Amino acid substitutions outside protein antigenic sites are very frequently assumed to exert no effect on binding to antiprotein antibodies, especially if these are monoclonal antibodies (mAbs). In fact, a very popular method for localization of residues in protein antigenic sites is based on the interpretation that whenever a replacement causes a change in binding to antibody, then that residue will be located in the antigenic site. To test this assumption, mAbs of predetermined specificity were prepared by immunization with a free (i.e., without coupling to any carrier) synthetic peptide representing region 94–100 of sperm whale myoglobin (Mb). The cross-reactivities and relative affinities of three mAbs with eight Mb variants were studied. Five Mb variants which had no substitutions within the boundaries of the designed antigenic site exhibited remarkable, and in two cases almost complete, loss in cross-reactivity relative to the reference antigen, sperm whale Mb. Two myoglobins, each of which had one substitution within region 94–100, showed little or no reactivity with the three mAbs. It is concluded that substitutions outside an antigenic site can exert drastic effects on the reactivity of a protein with mAbs against the site and that caution should be exercised in interpreting cross-reactivity data of proteins to implicate residues directly in an antigenic site.
    32 schema:genre article
    33 schema:isAccessibleForFree false
    34 schema:isPartOf N009c14aaa04d45aa8572a553859cd00b
    35 N01f310f54e1a456e8bc7bffb83021c99
    36 sg:journal.1297375
    37 schema:keywords MB
    38 Mb variants
    39 acid substitutions
    40 affinity
    41 amino acid substitutions
    42 antibodies
    43 antigen
    44 antigenic sites
    45 antiprotein antibodies
    46 assumption
    47 boundaries
    48 cases
    49 caution
    50 changes
    51 cross-reactivity data
    52 data
    53 demonstration
    54 drastic effect
    55 effect
    56 fact
    57 free synthetic peptide
    58 immunization
    59 interpretation
    60 localization
    61 localization of residues
    62 loss
    63 mAbs
    64 method
    65 monoclonal antibodies
    66 myoglobin
    67 peptide immunization
    68 peptides
    69 popular method
    70 predetermined specificity
    71 protein
    72 protein antigenic sites
    73 reactivity
    74 reference antigen
    75 relative affinity
    76 replacement
    77 residues
    78 sites
    79 specificity
    80 sperm whale Mb
    81 sperm whale myoglobin
    82 substitution
    83 synthetic peptides
    84 variants
    85 whale Mb
    86 whale myoglobin
    87 schema:name Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: Demonstration with region 94–100 (antigenic site 3) of myoglobin
    88 schema:pagination 433-444
    89 schema:productId N44caf16fc80443bd97cf948173022000
    90 Ndeabc3cf9c7b48d38247523e43a4cadf
    91 Necf45c13ad144784850ebf5841fa1240
    92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016163643
    93 https://doi.org/10.1007/bf01025020
    94 schema:sdDatePublished 2022-09-02T15:47
    95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    96 schema:sdPublisher Naf7701e6703f44ee87c255b943338381
    97 schema:url https://doi.org/10.1007/bf01025020
    98 sgo:license sg:explorer/license/
    99 sgo:sdDataset articles
    100 rdf:type schema:ScholarlyArticle
    101 N009c14aaa04d45aa8572a553859cd00b schema:volumeNumber 11
    102 rdf:type schema:PublicationVolume
    103 N01f310f54e1a456e8bc7bffb83021c99 schema:issueNumber 5
    104 rdf:type schema:PublicationIssue
    105 N0b17695191e048f8a24544a4f8d4b817 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Dolphins
    107 rdf:type schema:DefinedTerm
    108 N0e68937751a74b47bce4f048c2c1b720 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Antibodies, Monoclonal
    110 rdf:type schema:DefinedTerm
    111 N269d892068bf4d28bbdc54541766ee88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Tachyglossidae
    113 rdf:type schema:DefinedTerm
    114 N407ee46165124ad5b9ed5167826f952b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Epitopes
    116 rdf:type schema:DefinedTerm
    117 N44caf16fc80443bd97cf948173022000 schema:name doi
    118 schema:value 10.1007/bf01025020
    119 rdf:type schema:PropertyValue
    120 N4e416633fd8745148e677ba8c5dbf8b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Chickens
    122 rdf:type schema:DefinedTerm
    123 N5dfa40c770284e8e94c64df17c15c2f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Myoglobin
    125 rdf:type schema:DefinedTerm
    126 N7aac7c8f239c45e6a1f4c17ed2052e13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Antibody Specificity
    128 rdf:type schema:DefinedTerm
    129 N837b3d3af26f46bc92bf7f9dd7596658 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Dogs
    131 rdf:type schema:DefinedTerm
    132 N83d5e9b638a145c0a7f5f3eb09a83ccb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Peptide Fragments
    134 rdf:type schema:DefinedTerm
    135 N8418cd79479e497fbe177a7ddabda242 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Amino Acid Sequence
    137 rdf:type schema:DefinedTerm
    138 N8b834647a89143598126075f3a601477 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Immunization
    140 rdf:type schema:DefinedTerm
    141 N989c9cb5eb584255bde6abe8ccc84a37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Binding Sites, Antibody
    143 rdf:type schema:DefinedTerm
    144 Na8e4006c9ce4468796441ab58ec78742 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Carnivora
    146 rdf:type schema:DefinedTerm
    147 Naf7701e6703f44ee87c255b943338381 schema:name Springer Nature - SN SciGraph project
    148 rdf:type schema:Organization
    149 Nb497dda242ac4e328acd060caef801dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Animals
    151 rdf:type schema:DefinedTerm
    152 Nbf173c99c66c4407857493f204701959 rdf:first sg:person.010356667154.19
    153 rdf:rest Ndf644bf9c335456481870e2ecf09722a
    154 Nc81b48ce974642a9bf4af2c10dae4abd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Species Specificity
    156 rdf:type schema:DefinedTerm
    157 Nc93074d899374ad4b1d4294ee5eb5827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Whales
    159 rdf:type schema:DefinedTerm
    160 Ndeabc3cf9c7b48d38247523e43a4cadf schema:name pubmed_id
    161 schema:value 1280436
    162 rdf:type schema:PropertyValue
    163 Ndf644bf9c335456481870e2ecf09722a rdf:first sg:person.01022247072.83
    164 rdf:rest rdf:nil
    165 Ne45a5d486adf4b848e0655701eabd4ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Mice
    167 rdf:type schema:DefinedTerm
    168 Ne6b69568d67549aba37100f4f3ece91c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Structure-Activity Relationship
    170 rdf:type schema:DefinedTerm
    171 Necf45c13ad144784850ebf5841fa1240 schema:name dimensions_id
    172 schema:value pub.1016163643
    173 rdf:type schema:PropertyValue
    174 Nf1cab84bd6184771ac94dea321085b30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Molecular Sequence Data
    176 rdf:type schema:DefinedTerm
    177 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    178 schema:name Biological Sciences
    179 rdf:type schema:DefinedTerm
    180 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    181 schema:name Biochemistry and Cell Biology
    182 rdf:type schema:DefinedTerm
    183 sg:journal.1297375 schema:issn 1572-3887
    184 1573-4943
    185 schema:name The Protein Journal
    186 schema:publisher Springer Nature
    187 rdf:type schema:Periodical
    188 sg:person.01022247072.83 schema:affiliation grid-institutes:grid.39382.33
    189 schema:familyName Atassi
    190 schema:givenName M. Zouhair
    191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022247072.83
    192 rdf:type schema:Person
    193 sg:person.010356667154.19 schema:affiliation grid-institutes:grid.39382.33
    194 schema:familyName Abaza
    195 schema:givenName Mohamed-Salah I.
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010356667154.19
    197 rdf:type schema:Person
    198 sg:pub.10.1007/978-1-4613-3778-2_21 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037034586
    199 https://doi.org/10.1007/978-1-4613-3778-2_21
    200 rdf:type schema:CreativeWork
    201 sg:pub.10.1007/978-1-4613-4190-1_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017862294
    202 https://doi.org/10.1007/978-1-4613-4190-1_2
    203 rdf:type schema:CreativeWork
    204 sg:pub.10.1007/978-1-4613-4193-2_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1089828740
    205 https://doi.org/10.1007/978-1-4613-4193-2_4
    206 rdf:type schema:CreativeWork
    207 sg:pub.10.1007/978-1-4615-8858-0_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030236168
    208 https://doi.org/10.1007/978-1-4615-8858-0_2
    209 rdf:type schema:CreativeWork
    210 sg:pub.10.1038/202496a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006658233
    211 https://doi.org/10.1038/202496a0
    212 rdf:type schema:CreativeWork
    213 sg:pub.10.1038/205883a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009095762
    214 https://doi.org/10.1038/205883a0
    215 rdf:type schema:CreativeWork
    216 grid-institutes:grid.39382.33 schema:alternateName Department of Biochemistry, Baylor College of Medicine, 77030, Houston, Texas
    217 schema:name Department of Biochemistry, Baylor College of Medicine, 77030, Houston, Texas
    218 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...